“…developed a novel signature based on pyroptosis-related lncRNAs in BC, playing vital roles in cancer immunology and serving as potential therapeutic targets [ 32 ]. MAN1B1 was also revealed as a new biomarker for BC and strongly linked with immune cells infiltration degree [ 33 ]. As for this study, it was the first time for us to build a predictive signature for BC based on ARGs and to explore the correlations between our established signature and clinicopathological features.…”